Handok Pharmaceuticals Co., Ltd. - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Handok Pharmaceuticals Co., Ltd. Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Handok Pharmaceuticals Co., Ltd.. The Company's principal activities are manufacturing and distributing over-the-counter medicines. The Company's products include Amaryl for diabetes, Tritace for hypertension, myocardial infarction, heart failure and other cardiovascular disease, Teveten for essential hypertension, Festal for dyspepsia, Munobal for hypertension and stenocardia, Triapin for essential hypertension, Gatiflo for respiratory and other infective disease, Lasix for hypertension and edema, Ketas for disturbance of cerebral circulation and Dermatop for dermatology. In addition, the Company offers reagents and diagnostic instruments. It is also engaged in the real estate leasing business. The Company operates a research laboratory in Seoul and a plant in Chungcheongbuk-Do, Korea.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report